Literature DB >> 24043713

Human ERV3-1 env protein expression in various human tissues and tumours.

Yun-Jeong Kang1, Jin-Ok Jo, Mee Sun Ock, Hee-Kyung Chang, Kyung-Wan Baek, Ja-Rang Lee, Yung Hyun Choi, Wun-Jae Kim, Sun-Hee Leem, Heui-Soo Kim, Hee-Jae Cha.   

Abstract

Entities:  

Keywords:  Cancer; Histopathology; Virus

Mesh：

Substances：

Year:  2013        PMID： 24043713     DOI： 10.1136/jclinpath-2013-201841

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  5 in total

1.  Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma.

Authors:  Jun-Chieh J Tsay; Zhiguo Li; Ting-An Yie; Feng Wu; Leopoldo Segal; Alissa K Greenberg; Eric Leibert; Michael D Weiden; Harvey Pass; John Munger; Alexander Statnikov; Kam-Meng Tchou-Wong; William N Rom
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

2.  Identification and Expression Analyses of Equine Endogenous Retroviruses in Horses.

Authors:  Jeong-An Gim; Heui-Soo Kim
Journal:  Mol Cells       Date:  2017-10-17       Impact factor: 5.034

3.  Expression of human endogenous retrovirus env genes in the blood of breast cancer patients.

Authors:  Dong-Won Rhyu; Yun-Jeong Kang; Mee-Sun Ock; Jung-Woo Eo; Yung-Hyun Choi; Wun-Jae Kim; Sun-Hee Leem; Joo-Mi Yi; Heui-Soo Kim; Hee-Jae Cha
Journal:  Int J Mol Sci       Date:  2014-05-26       Impact factor: 5.923

Review 4.  Endogenous Retrovirus 3 - History, Physiology, and Pathology.

Authors:  Yomara Y Bustamante Rivera; Christine Brütting; Caroline Schmidt; Ines Volkmer; Martin S Staege
Journal:  Front Microbiol       Date:  2018-01-15       Impact factor: 5.640

5.  Expression profiles of human endogenous retrovirus (HERV)-K and HERV-R Env proteins in various cancers.

Authors:  Eun-Ji Ko; Kyoung Seob Song; Mee Sun Ock; Yung Hyun Choi; Suhkmann Kim; Heui-Soo Kim; Hee-Jae Cha
Journal:  BMB Rep       Date:  2021-07       Impact factor: 4.778
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.